ArticleEuropean journal of neurology2026

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.

Maiju Savolainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.